Company Overview - Doximity (DOCS) closed at $41.42, reflecting a -1.76% change from the previous day, underperforming the S&P 500's daily loss of 0.92% [1] - Over the last month, Doximity's shares increased by 1.91%, outperforming the Medical sector's loss of 4.16% but lagging behind the S&P 500's gain of 2.68% [1] Upcoming Earnings - Doximity's earnings report is expected on November 7, 2024, with an anticipated EPS of $0.26, representing an 18.18% increase year-over-year [1] - The consensus estimate for revenue is $127.05 million, indicating an 11.83% growth compared to the same quarter of the previous year [1] Full Year Estimates - For the full year, Zacks Consensus Estimates project earnings of $1.05 per share and revenue of $520.23 million, reflecting changes of +10.53% and +9.43% respectively from the previous year [2] - Recent modifications to analyst estimates indicate shifting business dynamics, with positive revisions suggesting analyst optimism regarding Doximity's business and profitability [2] Valuation Metrics - Doximity currently has a Forward P/E ratio of 39.98, which is a premium compared to the industry's average Forward P/E of 19.41 [3] - The company has a PEG ratio of 3.83, compared to the Medical Services industry's average PEG ratio of 1.85 [3] Industry Ranking - The Medical Services industry has a Zacks Industry Rank of 173, placing it in the bottom 32% of over 250 industries [3] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), shows that Doximity is currently rated 3 (Hold) [3]
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know